Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Med (Lausanne)
Auteurs principaux: Ballester-Clau, Raquel, Torres Vicente, Gisela, Cucala Ramos, Mercedes, Aracil Blanch, Carles, Miñana Calafat, Josep Maria, Pijoan Comas, Eva, Reñé Espinet, Josep Maria, Planella de Rubinat, Montse
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181670/
https://ncbi.nlm.nih.gov/pubmed/32363194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00128
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires